Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of GR37547 Ciprofloxacin vs Reference in Healthy Adults
NCT03150082Phase 1Completed
- Sponsor
- GSK
- Start
- Aug 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ciprofloxacin in bacterial infection (2 arms), sponsored by GSK. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time Zero to Last Time of Quantifiable Concentration and Maximum Observed Plasma Concentration. Started Aug 2017; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03150082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03150082.